Abstr ., 29 , 1-8
Furthermore, when we repeated the meta-analysis excluding ELIXA, the trial done with a short-acting GLP-1 receptor agonist in patients with acute coronary syndrome, the outcome of worsening of kidney function, based predominantly on change in eGFR, was also improved. Sattar and colleagues analyzed data from eight randomized, placebo-controlled trials with 60,080 participants testing injectable or oral GLP-1 receptor agonists in adults with type 2 diabetes, including the recently presented AMPLITUDE-O
Yes, it is safe for daily use
While NAD+ is the engine of energy and repair, glutathione is the shield against oxidative stress and environmental toxins
Observational real-world data in patients with T2D receiving oral semaglutide for 26 weeks demonstrated preservation of fat-free and skeletal muscle mass despite significant losses in fat mass and visceral adipose tissue, suggesting that the magnitude of lean tissue change may depend on concomitant lifestyle behaviors, such as physical activity and diet [16]
They found out that monoglycerides were more active against all tested microorganisms, except Listeria monocytogenes , which exhibited pronounced inhibition with MCFAs, especially C12:0 with MIC of 31.25 g/ml